{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:26:54Z","timestamp":1768465614890,"version":"3.49.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Cardiac amyloidoses are the most fatal manifestation of systemic amyloidoses. It is believed the number of cases to be greatly underestimated mostly due to misdiagnosis. Particularly, the involvement of TTR V30M in the heart of ATTRV30M amyloidosis has not been completely understood specifically in terms of implicated cellular pathways, heart function and cardiac physiology. In the present work we proposed to characterize TTR V30M cardiac involvement particularly at the tissue cellular level in a mouse model.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> HSF \u00b1 hTTR V30M mice, a model that expresses human TTRV30M in a Ttr null background, widely used for the characterization and modulation of neurological features of ATTRV30M amyloidosis was used. SDS-PAGE of cardiac homogenates followed by Western blot was performed. Immunohistochemistry and double immunofluorescence analyses were carried out to determine TTR deposition pattern and sub-localization.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Western blots were able to detect TTR in its monomeric state at \u223c14\u00a0kDa. Immunofluorescent images showed TTR was found mostly in the intercellular spaces. Blood contamination was excluded by CD31 staining. Tissues were Congo Red negative. Upon TTR and macrophages (CD68) staining in the cardiac tissue a clear tendency of macrophage convergence to the tissue regions where TTR was more abundant was observed. Moreover, in some instances it was possible to detect co-localization of both fluorophores. Cardiac fibroblasts were stained with PDGFr-alpha, and here the co-localization was not so evident although there was some degree of co-occurrence. The hearts of transgenic mice revealed higher content of Galectin-3.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This animal model and associated features observed as result of cardiac TTR deposition provide a promising and invaluable research tool for a better understanding of the implicated pathways that lead to the lethality associated to TTR cardiac amyloidosis. New therapeutic strategies can be tested and ultimately this will lead to improved treatment alternatives capable of increasing patient\u2019s quality of life and life expectancy and, hopefully to eradicate a condition that is silently spreading worldwide.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1144049","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T04:27:45Z","timestamp":1678249665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Cellular environment of TTR deposits in an animal model of ATTR\u2014Cardiomyopathy"],"prefix":"10.3389","volume":"10","author":[{"given":"Cristina","family":"Teixeira","sequence":"first","affiliation":[]},{"given":"Helena Sofia","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Saraiva","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation","volume":"115","author":"Ali","year":"2014","journal-title":"Circ. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1021\/bi101822y","article-title":"Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion","volume":"50","author":"Bourgault","year":"2011","journal-title":"Biochemistry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/13506129.2016.1160882","article-title":"Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis","volume":"23","author":"Butler","year":"2016","journal-title":"Amyloid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: Studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.stem.2011.10.002","article-title":"Adult cardiac-resident MSC-like stem cells with a proepicardial origin","volume":"9","author":"Chong","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1089\/scd.2012.0542","article-title":"Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart","volume":"22","author":"Chong","year":"2013","journal-title":"Stem Cells Dev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"26623","DOI":"10.1038\/srep26623","article-title":"Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis","volume":"6","author":"Ferreira","year":"2016","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s13311-013-0256-8","article-title":"Molecular tweezers targeting transthyretin amyloidosis","volume":"11","author":"Ferreira","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2018.01.128","article-title":"Galectin-3 in the fibrotic response: Cellular targets and molecular mechanisms","volume":"258","author":"Frangogiannis","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","article-title":"Myocardial galectin-3 expression is associated with remodeling of the pressure-overloaded heart and may delay the hypertrophic response without affecting survival, dysfunction, and cardiac fibrosis","volume":"186","author":"Frunza","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/CIRCRESAHA.115.303567","article-title":"Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction","volume":"115","author":"Heidt","year":"2014","journal-title":"Circ. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","article-title":"Resident fibroblast expansion during cardiac growth and remodeling","volume":"114","author":"Ivey","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"29643","DOI":"10.18632\/oncotarget.16772","article-title":"Platelet-derived growth factor receptor-alpha positive cardiac progenitor cells derived from multipotent germline stem cells are capable of cardiomyogenesis in vitro and in vivo","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cca.2009.09.001","article-title":"The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients","volume":"409","author":"Lin","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"B18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","article-title":"Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: Insights from the CARE-HF (cardiac resynchronization in heart failure) trial","volume":"14","author":"Lopez-Andres","year":"2012","journal-title":"Eur. J. Heart Fail"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-\u03b21-driven lung fibrosis by galectin-3","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Martinez-Martinez","year":"2015","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1038\/s41467-021-23274-x","article-title":"A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells","volume":"12","author":"Michalon","year":"2021","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/labinvest.2013.83","article-title":"Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis","volume":"93","author":"Misumi","year":"2013","journal-title":"Lab. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/path.2618","article-title":"Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy","volume":"219","author":"Misumi","year":"2009","journal-title":"J. Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"H1169","DOI":"10.1152\/ajpheart.00337.2017","article-title":"Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by \u03b22-adrenoceptor overexpression","volume":"314","author":"Nguyen","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1073\/pnas.1101194108","article-title":"Heparan sulfate\/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein","volume":"108","author":"Noborn","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1038\/ncomms7930","article-title":"PDGFR\u03b1 demarcates the cardiogenic clonogenic Sca1+ stem\/progenitor cell in adult murine myocardium","volume":"6","author":"Noseda","year":"2015","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting cardiac cellular composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/13.8.693","article-title":"Congo red as a stain for fluorescence microscopy of amyloid","volume":"13","author":"Puchtler","year":"1965","journal-title":"J. Histochem Cytochem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2008.04.001","article-title":"The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems","volume":"31","author":"Santos","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1096\/fj.04-2022fje","article-title":"Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy","volume":"19","author":"Sousa","year":"2005","journal-title":"FASEB J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yjmcc.2016.01.011","article-title":"Extracellular matrix-mediated cellular communication in the heart","volume":"91","author":"Valiente-Alandi","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","article-title":"Cardiac interstitium in health and disease: The fibrillar collagen network","volume":"13","author":"Weber","year":"1989","journal-title":"J. Am. Coll. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ. Heart Fail"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1144049\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T04:27:48Z","timestamp":1678249668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1144049\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":36,"alternative-id":["10.3389\/fmolb.2023.1144049"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1144049","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1144049"}}